Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Notes Payables (2020 - 2025)

Bio Essence has reported Notes Payables over the past 6 years, most recently at $1531.0 for Q4 2025.

  • For Q4 2025, Notes Payables changed N/A year-over-year to $1531.0; the TTM value through Dec 2025 reached $1531.0, changed N/A, while the annual FY2025 figure was $1531.0, N/A changed from the prior year.
  • Notes Payables for Q4 2025 was $1531.0 at Bio Essence, down from $6966.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $70860.0 in Q1 2023 and troughed at $1531.0 in Q4 2025.
  • A 5-year average of $22537.6 and a median of $19032.0 in 2021 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: soared 158.61% in 2023 and later plummeted 96.43% in 2024.
  • Year by year, Notes Payables stood at $19032.0 in 2021, then rose by 14.62% to $21815.0 in 2022, then crashed by 56.75% to $9436.0 in 2023, then crashed by 73.17% to $2532.0 in 2024, then plummeted by 39.53% to $1531.0 in 2025.
  • Business Quant data shows Notes Payables for BIOE at $1531.0 in Q4 2025, $6966.0 in Q2 2025, and $2414.0 in Q1 2025.